Towards a glioma model for surgical technique evaluation in the rat

Abstract Introduction. Evaluation of new surgical techniques in animal models is frequently challenging. This article describes the pitfalls, peculiarities and the final best applicable model for evaluating surgical techniques for glioma resection. Methods. The C6 glioma cell line and the Sprague-Dawley rat strain were selected. Fifty-thousand glioma cells were stereotactically transplanted in the left hemisphere of 137 male adult rats. Evaluation of solid tumour formation, tumour growth and scheduling of surgical resection was performed by MR scanning at 1, 2, and 4 weeks after transplantation and 3 and 6 months after tumour resection. Microsurgical tumour resection was performed with conventional techniques or with the waterjet dissector at a pressure of 6 bar. One subgroup of each surgical technique was sacrificed directly after surgery for histological analysis. The other subgroup was followed up for long-term analysis. Results. The transplantation site was of great importance. After transplantation of tumour cells posterior to the bregma, intra-ventricular tumour growth with spreading occurred. Homogenous and reproducible tumour growth was achieved after grafting cells lateral − 3 mm, anterior + 1 mm, and − 2.5 mm ventral to the bregma. After development of solid tumours on MR imaging, animals were subjected to surgery. MR and intra-operative findings corresponded well. However, MRI and intra-operative none-detectable perivascular tumour spreading was histologically observed in the majority of cases. Conclusions. The presented glioma rat model consisting of the C6 cell line and Sprague-Dawley rats as recipients is a well-suited model to investigate surgical techniques and their impact on tumour therapy. However, the site of transplantation, the preparation of cell grafts and the technique of tumour growth evaluation is of utmost importance to achieve reliable results.

[1]  M. Weller,et al.  New (alternative) temozolomide regimens for the treatment of glioma. , 2009, Neuro-oncology.

[2]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[3]  C. Jackson-Cook,et al.  Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma+vaccination model , 2010, Journal of Neuroimmunology.

[4]  Scott VandenBerg,et al.  Bromophenol Blue Staining of Tumors in a Rat Glioma Model , 2005, Neurosurgery.

[5]  J. Oertel,et al.  Waterjet resection of brain metastases - first clinical results with 10 patients. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Martin Goetz,et al.  Confocal Laser Endomicroscopy for Diagnosis and Histomorphologic Imaging of Brain Tumors In Vivo , 2012, PloS one.

[7]  Xiaoyuan Chen,et al.  In Vivo MRI Tracking of Cell Invasion and Migration in a Rat Glioma Model , 2011, Molecular Imaging and Biology.

[8]  D. Groothuis,et al.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research , 1991, Journal of Neuro-Oncology.

[9]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.

[10]  John S. Winestone,et al.  Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection , 2009, Journal of Neuro-Oncology.

[11]  J. Mosser,et al.  Overview of Cellular Immunotherapy for Patients with Glioblastoma , 2010, Clinical & developmental immunology.

[12]  J. Oertel,et al.  Waterjet dissection in neurosurgical procedures: clinical results in 35 patients. , 2002, Journal of neurosurgery.

[13]  Bert Grobben,et al.  Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion , 2002, Cell and Tissue Research.

[14]  G. Ojemann,et al.  Correlation of intraoperative ultrasound tumor volumes and margins with preoperative computerized tomography scans. An intraoperative method to enhance tumor resection. , 1989, Journal of neurosurgery.

[15]  M. Chopp,et al.  Combination of Surgical Resection and Photodynamic Therapy of 9L Gliosarcoma in the Nude Rat , 2006, Photochemistry and photobiology.

[16]  L. Levine,et al.  Differentiated Rat Glial Cell Strain in Tissue Culture , 1968, Science.

[17]  J. Tonn,et al.  Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats , 2005, Cancer Immunology, Immunotherapy.

[18]  H. Schroeder,et al.  Waterjet dissection of gliomas -- experience with 51 procedures. , 2004, Minimally invasive neurosurgery : MIN.

[19]  J. Piek,et al.  Waterjet dissection in the brain: review of the experimental and clinical data with special reference to meningioma surgery , 2003, Neurosurgical Review.

[20]  Jörg-Christian Tonn,et al.  Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. , 2008, Clinical neurosurgery.

[21]  J. Oertel,et al.  Water Jet Dissection in Neurosurgery: An Update After 208 Procedures With Special Reference to Surgical Technique and Complications , 2010, Neurosurgery.

[22]  Oren Sagher,et al.  The Brain Tumor Window Model: A Combined Cranial Window and Implanted Glioma Model for Evaluating Intraoperative Contrast Agents , 2010, Neurosurgery.

[23]  Michelle J Hickey,et al.  Cellular and vaccine therapeutic approaches for gliomas , 2010, Journal of Translational Medicine.

[24]  M. Bernstein,et al.  Effect of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model: implications for brain tumor therapy. , 1997, Neurosurgery.

[25]  Christopher Nimsky,et al.  Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. , 2004, Journal of neurosurgery.

[26]  Dwaine F. Emerich,et al.  Injectable Chemotherapeutic Microspheres and Glioma I: Enhanced Survival Following Implantation into the Cavity Wall of Debulked Tumors , 2000, Pharmaceutical Research.

[27]  T. Ryken,et al.  Genetic characterization of commonly used glioma cell lines in the rat animal model system. , 2005, Neurosurgical focus.

[28]  H. Schroeder,et al.  Prognosis of gliomas in the 1970s and today. , 2005, Neurosurgical focus.

[29]  W. Mason,et al.  Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.

[31]  H. Schroeder,et al.  Waterjet Dissection versus Ultrasonic Aspiration in Epilepsy Surgery , 2005, Neurosurgery.

[32]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas , 2009, Journal of Neuro-Oncology.